Atlas Trials

A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)

Clinical trial NCT06223360 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06223360
Sponsor
Alzheimer's Disease Cooperative Study (ADCS)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2024-03-28
Primary completion
2027-12-01
Enrollment
406

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.